Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ryan M. Kahn"'
Autor:
Ryan M. Kahn, Sushmita Gordhandas, Eloise Chapman-Davis, Elizabeth Margolskee, Cathleen Matrai, Amy Chadburn, Ellen Ritchie
Publikováno v:
Case Reports in Oncological Medicine, Vol 2019 (2019)
Myeloid sarcoma (MS) is a rare, extramedullary tumor consisting of immature white blood cells of myeloid lineage. MS is usually associated with the concurrent diagnosis of acute myeloid leukemia (AML) but can also present in the absence of bone marro
Externí odkaz:
https://doaj.org/article/6bc8ab1f08c44bc6921dcf5d227c8b12
Autor:
Beryl L. Manning‐Geist, Ryan M. Kahn, David Nemirovsky, Jeffrey Girshman, Anya Laibangyang, Sushmita Gordhandas, Alexia Iasonos, M. Herman Chui, Kara Long Roche, Oliver Zivanovic, Dennis S. Chi, Carol Aghajanian, Rachel N. Grisham
Publikováno v:
Cancer.
Autor:
Ryan M. Kahn, Erin McMinn, Effi Yeoshoua, Thomas Boerner, Qin Zhou, Alexia Iasonos, Kara Long Roche, Oliver Zivanovic, Ginger J. Gardner, Yukio Sonoda, Roisin E. O'Cearbhaill, Rachel N. Grisham, William Tew, David Jones, James Huang, Bernard J. Park, Nadeem R. Abu-Rustum, Dennis S. Chi
Publikováno v:
Gynecologic oncology. 170
We investigated the feasibility, safety, and survival outcomes of intrathoracic cytoreduction during primary debulking surgery (PDS) for advanced ovarian cancer.We conducted a database review of patients with stage IIIB-IV ovarian (including fallopia
Autor:
Ryan M. Kahn, Govind Ragupathi, Qin C. Zhou, Alexia Iasonos, Sara Kravetz, Martee L. Hensley, Jason A. Konner, Vicky Makker, William P. Tew, Carol Aghajanian, Paul J. Sabbatini, Roisin E. O’Cearbhaill
Background: To characterize the safety, immunogenicity, and outcomes of patients with high-grade serous ovarian cancer (HGSOC) in second or greater remission treated with a polyvalent antigen-KLH plus OPT-821 vaccine construct and bevacizumab. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f400500ca52865b5c4593c0ebd214e
https://doi.org/10.21203/rs.3.rs-1347080/v1
https://doi.org/10.21203/rs.3.rs-1347080/v1
Autor:
Ryan M, Kahn, Govind, Ragupathi, Qin C, Zhou, Alexia, Iasonos, Sara, Kravetz, Martee L, Hensley, Jason A, Konner, Vicky, Makker, William P, Tew, Carol, Aghajanian, Paul J, Sabbatini, Roisin E, O'Cearbhaill
Publikováno v:
Cancer immunology, immunotherapy : CII. 72(1)
To characterize the safety, immunogenicity, and outcomes of patients with high-grade serous ovarian cancer (HGSOC) in second or greater remission treated with a polyvalent antigen-KLH plus OPT-821 vaccine construct and bevacizumab.Patients with recur
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:616-617
Autor:
Andre Pinto, Charles M. Quick, Marilyn Huang, Brian M. Slomovitz, Andrew E. Rosenberg, Michella K. Whisman, Ryan M. Kahn
Publikováno v:
Human pathology. 74
Rhabdomyosarcoma (RMS) is an aggressive mesenchymal tumor most commonly diagnosed in the pediatric population, and when occurring in adults, tends to develop in the deep soft tissue of the limbs. Primary uterine RMS comprises an even more restricted